We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Minimally Invasive Surgery Proven Safe and Effective for Complex ‘Whipple’ Procedure

By HospiMedica International staff writers
Posted on 29 Dec 2025

Tumors of the pancreatic head often require a highly complex operation known as pancreatoduodenectomy or the Whipple procedure. More...

This surgery involves removing multiple structures and creating several internal reconnections, making it one of the most demanding abdominal operations. Traditionally performed as open surgery, it carries substantial recovery time and complication risks. New clinical trial evidence now shows that a less invasive approach can achieve similar safety while improving recovery.

The trial, coordinated by Amsterdam UMC (Amsterdam, The Netherlands), in collaboration with leading European surgical centers, evaluated minimally invasive pancreatoduodenectomy, performed using advanced laparoscopic and robotic techniques, and compared it with conventional open surgery. The minimally invasive approach uses small incisions and robotic assistance to enhance visualization, precision, and dexterity during tumor removal and reconstruction of pancreatic, biliary, and gastric connections.

The international DIPLOMA-2 randomized clinical trial included 288 patients treated across 14 expert centers in six European countries. Patients were assigned in a 2:1 ratio to minimally invasive or open surgery and monitored for postoperative outcomes over 90 days. Results showed comparable overall complication rates between both groups, with the minimally invasive group experiencing shorter hospital stays, fewer wound complications, and fewer anastomotic leaks.

The findings, published in New England Journal of Medicine Evidence, confirm that minimally invasive surgery is a safe alternative for pancreatic head tumors when performed in high-volume expert centers. Faster recovery and reduced surgical trauma may improve the quality of life and postoperative resilience for patients undergoing this demanding procedure. Researchers have launched a follow-up trial, DIPLOMA-2x2, to assess whether long-term cancer outcomes with robotic surgery are comparable to open approaches in malignant cases.

“These results mark an important turning point,” said co-principal investigator Dr. Mohammad Abu Hilal. “Minimally invasive surgery can now be considered a fully valid alternative even for the most complex pancreatic operation.”

Related Links:
Amsterdam UMC


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.